Literature DB >> 4393764

Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat.

J L Cohen, J Y Jao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4393764

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  33 in total

1.  Effects of elevated temperature on misonidazole O-demethylation by mouse liver microsomes: kinetic and stability studies of a model mixed-function oxidase reaction.

Authors:  M I Walton; N M Bleehen; P Workman
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  L B Grochow; M Colvin
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

3.  Disaggregation of mouse liver polysomes by cyclophosphamide.

Authors:  F V Plapp; M Chiga
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

4.  Mutagenic activity of cyclophosphamide, ifosfamide, and trofosfamide in different genes of escherichia coli and salmonella typhimurium after biotransformation through extracts of rodent liver.

Authors:  J Ellenberger; G Mohn
Journal:  Arch Toxicol       Date:  1975       Impact factor: 5.153

5.  The effect of chloramphenicol and sulphaphenazole on the biotransformation of cyclophosphamide in man.

Authors:  O K Faber; H T Mouridsen; L Skovsted
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

Review 6.  Dose-dependent pharmacokinetics and cancer chemotherapy.

Authors:  G Powis; M M Ames; J S Kovach
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

7.  Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide).

Authors:  D S Alberts; J G Einspahr; R Struck; G Bignami; L Young; E A Surwit; S E Salmon
Journal:  Invest New Drugs       Date:  1984       Impact factor: 3.850

8.  Antipyrine metabolism in cancer patients.

Authors:  T Higuchi; T Nakamura; H Uchino
Journal:  Experientia       Date:  1980-02-15

9.  Carbon tetrachloride-induced increase in the antitumor activity of cyclophosphamide in mice: a pharmacokinetic study.

Authors:  R N Harris; P J Basseches; P L Appel; A M Durski; G Powis
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

10.  Pharmacokinetics of high-dose cyclophosphamide in patients with metastatic bronchogenic carcinoma.

Authors:  P M Wilkinson; P A O'Neill; N Thatcher; S B Lucas
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.